1-[5-[2-chloro-5-(trifluoromethyl)phenyl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine
C18H18ClF3N6S — CID 155796692
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-[2-chloro-5-(trifluoromethyl)phenyl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine
1-[5-[2-chloro-5-(trifluoromethyl)phenyl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine (PubChem CID 155796692) has the molecular formula C18H18ClF3N6S and a molecular weight of 442.90 g/mol. Its IUPAC name is 1-[5-[2-chloro-5-(trifluoromethyl)phenyl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine.
Molecular Properties
| Compound Name | 1-[5-[2-chloro-5-(trifluoromethyl)phenyl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine |
|---|---|
| PubChem CID | 155796692 |
| Molecular Formula | C18H18ClF3N6S |
| Molecular Weight | 442.90 g/mol |
| Exact Mass | 442.10 |
| IUPAC Name | 1-[5-[2-chloro-5-(trifluoromethyl)phenyl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine |
| SMILES | CC1(N)CCN(c2nc3ncc(Sc4cc(C(F)(F)F)ccc4Cl)nc3[nH]2)CC1 |
| InChI | InChI=1S/C18H18ClF3N6S/c1-17(23)4-6-28(7-5-17)16-26-14-15(27-16)25-13(9-24-14)29-12-8-10(18(20,21)22)2-3-11(12)19/h2-3,8-9H,4-7,23H2,1H3,(H,24,25,26,27) |
| InChIKey | LZNFRDBZQNPVRJ-UHFFFAOYSA-N |
| XLogP | 4.49 |
| TPSA | 83.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 442.90 |
| LogP ≤ 5 | 4.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155796692 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.